CureSearch Directors provide outstanding executive leadership, experience and expertise from the areas of business, finance, medical research, and more. Many directors have experienced childhood cancer in their own families or with close friends, and they understand the challenges facing patients and families today.
Chair of the Board
Jared Brancazio, WMS®
Currently VP, Investments at Brancazio Wealth Management of Raymond James, Mr. Brancazio has spent more than 20 years in high level finance and investment roles and has also served in key volunteer leadership roles at organizations including the Leukemia & Lymphoma Society, Florida Cancer Specialists Foundation and Florida Southwestern State College Foundation. Mr. Brancazio, himself a cancer survivor, previously served as Board Treasurer.
Secretary
Suzanne Finnegan
Director & Chief Credit Officer at Build America Mutual
Assurance Company
Treasurer
Trent Demulling
Chief Financial Officer at Kiewit
Members
Ali Frost
Vice-Chair, Marketing Committee
CMO, The Bay Golf Club
Brenda Weigel, MD
Chair, Scientific Advisory Council
Director, Division of Pediatric Hematology/Oncology at University of Minnesota
Cason Carter
Strategy Oversight Committee
Director, Head of Public Affairs at Citadel, LLC
Cherry Trivedi
Chair, Audit Committee
CEO at Ayuroma Advisory International
Dave Kupiec
Chair, Marketing Committee
CEO/Founder at KPI Media Partners
Dave Whan
Development Committee
Executive Partner - CHRO at Gartner
Greg Hill
Executive VP, Kiewit Infrastructure Group Inc.
Jeffrey Skolnik
Chair, Industry Advisory Council
Senior Vice President of Clinical Development at Inovio
Kathy Wanner
Nominating Committee
Founding Partner at Fairway Capital Management
Mike Miller, Esquire
Emeritus, Board of Directors
Senior Council at Fisher & Phillips, LLP
Sam Blackman, MD, PhD
Strategy Oversight Committee
Co-Founder & Chief Medical Officer at Day One Biopharmaceuticals
Shari Collier
CureSearch Audit Chair
Division CFO at St. David's HealthCare
Stacey Adam, PhD
Chair, Strategy Oversight Committee
Director of Cancer Research Partnerships at FNIH
Stu E. Siegel, MD
Chair Emeritus, Board of Directors
Retired Director at Children's Hospital Los Angeles
Tina Swallow
Development Committee
Sales Director, DoD at Trellix
Paula and Mike Carter
Members, Emeriti
Co-Founders, Scott Carter Foundation
John Polson
Board of Directors
Chairman and Managing Partner of Fisher Phillips
Strategy Oversight Committee
The Strategy Oversight Committee fosters a cooperative, interactive strategic planning process between the Board and management.
Stacey Adam, PhD, Chair
Associate Vice President, Research Partnerships
Foundation for the National Institutes of Health
Members
Cason Carter
Director, Head of Public Affairs
Citadel, LLC
Samuel C. Blackman, MD, PhD,
Co-founder & Chief Medical Officer
Day One Biopharmaceuticals
Syril Petit
Executive Director
Health and Environmental Sciences Institute (HESI)
Chris Lee
Managing Director, Strategy & Corporate Development
Palladium
Gordon Cohen
Global Clinical Head
Lou Stancato, PhD
VP of Enabling Technologies and Global Leader of the Pediatric Rare Disease Platform
Indiana Biosciences Research Institute